glabridin has been researched along with carbon tetrachloride in 1 studies
| Studies (glabridin) | Trials (glabridin) | Recent Studies (post-2010) (glabridin) | Studies (carbon tetrachloride) | Trials (carbon tetrachloride) | Recent Studies (post-2010) (carbon tetrachloride) |
|---|---|---|---|---|---|
| 172 | 4 | 122 | 8,804 | 11 | 2,582 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, J; Li, H; Sun, J; Xu, W; Yuan, N; Zhang, H; Zhang, L | 1 |
1 other study(ies) available for glabridin and carbon tetrachloride
| Article | Year |
|---|---|
Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARĪ³ in carbon tetrachloride-treated mice.
Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Fibronectins; Hepatic Stellate Cells; Inflammation; Liver; Liver Cirrhosis; Mice; Oxidative Stress; PPAR gamma; Procollagen; RNA, Messenger | 2022 |